Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joshua P Cohen

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
New Biotechnology|February 29, 2012
Overcoming regulatory and economic challenges facing pharmacogenomicsJoshua P Cohen
Expert Review of Pharmacoeconomics & Outcomes Research|July 21, 2012
Evaluating the impact of Medicare Part D on quality metricsJoshua P Cohen
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|April 25, 2020
Is There a Future for Value-Based Contracting?Joshua P Cohen
JAMA|June 22, 2006
Cost-effectiveness and resource allocationJoshua P Cohen
Personalized Medicine|May 23, 2018
Personalized medicine: are payers the weak link?Joshua P Cohen
Clinical Therapeutics|March 28, 2015
Implementing the affordable care act: remaining hurdlesJoshua P Cohen
Clinical Therapeutics|March 26, 2013
Comparative-effectiveness research: does it matter?Joshua P Cohen
Biomarkers in Medicine|January 22, 2015
Roadblocks preventing personalized medicine from reaching its potentialJoshua P Cohen
Journal of Market Access & Health Policy|May 27, 2016
Are payers treating orphan drugs differently?Joshua P Cohen, Abigail Felix
Molecular Diagnosis & Therapy|April 12, 2015
Can genomic medicine improve financial sustainability of health systems?Christine Y Lu, Joshua P Cohen
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
New Biotechnology|February 29, 2012
Overcoming regulatory and economic challenges facing pharmacogenomicsJoshua P Cohen
Expert Review of Pharmacoeconomics & Outcomes Research|July 21, 2012
Evaluating the impact of Medicare Part D on quality metricsJoshua P Cohen
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|April 25, 2020
Is There a Future for Value-Based Contracting?Joshua P Cohen
JAMA|June 22, 2006
Cost-effectiveness and resource allocationJoshua P Cohen
Personalized Medicine|May 23, 2018
Personalized medicine: are payers the weak link?Joshua P Cohen
Clinical Therapeutics|March 28, 2015
Implementing the affordable care act: remaining hurdlesJoshua P Cohen
Clinical Therapeutics|March 26, 2013
Comparative-effectiveness research: does it matter?Joshua P Cohen
Biomarkers in Medicine|January 22, 2015
Roadblocks preventing personalized medicine from reaching its potentialJoshua P Cohen
Journal of Market Access & Health Policy|May 27, 2016
Are payers treating orphan drugs differently?Joshua P Cohen, Abigail Felix
Molecular Diagnosis & Therapy|April 12, 2015
Can genomic medicine improve financial sustainability of health systems?Christine Y Lu, Joshua P Cohen
Pageof 3